Oral formulations and lipophilic salts of methylnaltrexone
AssigneeWyeth
InventorsSyed M. Shah, Christopher Richard Diorio, Eric C. Ehrnsperger, Xu Meng, Kadum A. Al Shareffi, Jonathan Marc Cohen
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
Claims30
A pharmaceutical composition for oral administration comprising a solid dosage of (i) methylnaltrexone bromide, and (ii) sodium dodecyl sulfate (SDS), wherein the composition is a tablet, wherein methylnaltrexone bromide is the sole active agent, and wherein the composition comprises from about 7% to about 75% methylnaltrexone cation and dodecyl sulfate anion, based upon the total weight of the composition.
A pharmaceutical composition for oral administration comprising a solid dosage of (i) methylnaltrexone bromide, and (ii) sodium dodecyl sulfate (SDS), wherein the composition is a tablet, wherein methylnaltrexone bromide is the sole active agent, wherein the composition comprises about 7% to about 75% of methylnaltrexone cation and dodecyl sulfate anion, based upon total weight of the composition;
- and wherein the composition further comprises
- (a) a chelating agent comprising calcium EDTA disodium;
- (b) a binder comprising microcrystalline cellulose;
- (c) a glidant comprising colloidal silicon dioxide;
- and
- (d) magnesium stearate and talc.
Dependencies are inferred from the claim text.